Business Services Industry
POZEN to Present at the RBC Capital Markets 2007 Healthcare Conference
Business Wire, Nov 28, 2007
CHAPEL HILL, N.C. -- POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the company's chairman, president and chief executive officer, will participate in the "Deliver Us From Pain" panel discussion at the RBC Capital Markets 2007 Healthcare Conference on Wednesday, December 12, 2007 at 11:00 a.m. (ET) at the Westin Times Square Hotel in New York City. The event will be webcast and archived on POZEN's home page at www.pozen.com.
POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN's efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline for the proposed product candidate Trexima[TM] for the acute treatment of migraine, which is currently under review by the United States Food and Drug Administration, and with AstraZeneca for the proposed product candidate PN 400 for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Content provided in partnership with
Most Recent Business Articles
- Freudenberg IT Invests $38 Million for Growth
- Research and Markets: Israel Ophthalmic Devices Investment Opportunities, Analysis and Future Forecasts Through to 2015
- Research and Markets: Emerging APAC (China) Networking Opportunity 2009 - Addressing a Growing Demand in a Downturn Economy
- Research and Markets: Indian Small & Medium Businesses SaaS Channel Partners 2009 - A Growing Opportunity in a Challenging Business Environment
- Research and Markets: Nippon Oil Corporation LNG Export and Import Markets, 2000 to 2015 Report - Profile and Analysis and Forecasts of Terminal Wise Capacity and Associated Contracts
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- Using object-oriented analysis and design over traditional structured analysis and design
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions



